IP Library Granted Patent US 8,552,051
Granted Patent B2
US 8,552,051 · App. 13/256,686 · Granted Oct 8, 2013

Use of pharmaceutical compositions containing mesembrenone

Inventors: Alan Harvey (Glasgow, GB); Nigel Gericke (Cape Town, ZA); Alvaro Viljoen (Cresta, ZA)
Assignee: H. L. Hall & Sons Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,552,051
App. No.
13/256,686
Granted
Oct 8, 2013
Kind
B2
Abstract

The use of mesembrenone and medicaments and dietary supplements containing mesembrenone. The applicant has surprisingly found that mesembrenone exhibits potent PDE-4 inhibition properties and, in addition to being useful in treating conditions that respond to treatment with a PDE-4 inhibitor, has dual activity on account of its serotonin-uptake inhibition properties. Mesembrenone is extracted and isolated, for example as a pure compound, from plant material of the plant family Mesembryanthemaceae. Preferably a plant or plants from the genus Sceletium , more preferably, Sceletium tortuosum (L) N.E.Br is used.

Claims (19)

1. A method of modulating PDE-4 activity in an individual, comprising administering to the individual mesembrenone or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 , wherein the mesembrenone is extracted and isolated from plant material of the plant family Mesembryanthemaceae.

3. The method of claim 1 , wherein the mesembrenone is in the form of a plant extract from plant material of the plant family Mesembryanthemaceae.

4. The method of claim 3 , where the mesembrenone is obtained from plant material of a plant or plants of the genus Sceletium.

5. The method of claim 4 , wherein the mesembrenone is obtained from plant material of a plant or plants of the species Sceletium tortuosum (L.) N.E.Br.

6. The method of claim 1 , wherein the mesembrenone or the pharmaceutically acceptable salt thereof is administered as a dietary supplement.

7. A method of inhibiting PDE-4 activitiy in an individual, comprising administering to the individual mesembrenone, or a pharmaceutically acceptable salt thereof.

8. A method of inhibiting PDE-4 activity and 5HT-uptake in an individual, comprising administering to the individual mesembrenone, or a pharmaceutically acceptable salt thereof.

9. The method of claim 1 , wherein the individual is a healthy individual.

10. The method of claim 7 , wherein the mesembrenone is extracted and isolated from plant material of the plant family Mesembryanthemaceae.

11. The method of claim 7 , wherein the mesembrenone is in the form of a plant extract from plant material of the plant family Mesembryanthemaceae.

12. The method of claim 7 , wherein the mesembrenone is obtained from plant material of a plant or plants of the genus Sceletium.

13. The method of claim 7 , wherein the mesembrenone is obtained from plant material of a plant or plants of the species Sceletium tortuosum (L.) N.E.Br.

14. The method of claim 7 , wherein the individual is a healthy individual.

15. The method of claim 8 , wherein the mesembrenone is extracted and isolated from plant material of the plant family Mesembryanthemaceae.

16. The method of claim 8 , wherein the mesembrenone is in the form of a plant extract from plant material of the plant family Mesembryanthemaceae.

17. The method of claim 8 , wherein the mesembrenone is obtained from plant material of a plant or plants of the genus Sceletium.

18. The method of claim 8 , wherein the mesembrenone is obtained from plant material of a plant or plants of the species Sceletium tortuosum (L.) N.E.Br.

19. The method of claim 8 , wherein the individual is a healthy individual.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2016
From: H.L. HALL & SONS (PTY) LTD
To: HG&H PHARMACEUTICALS (PTY) LTD
Reel/Frame 040143/0442 →
CHANGE OF NAME Recorded Oct 26, 2016
From: H.L. HALL & SONS LIMITED
To: H.L. HALL & SONS (PTY) LTD
Reel/Frame 040510/0127 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2011
From: HARVEY, ALAN; GERICKE, NIGEL; VILJOEN, ALVARO
To: H.L. HALL & SONS LIMITED
Reel/Frame 026945/0949 →
Priority Claims (1)
ZA 2009/02003 · Mar 20, 2009 · national
Continuity (1)
Related Publication 20120041045A1 · Feb 16, 2012